Evofem Biosciences Inc (EVFM)

Evofem Biosciences (EVFM) Income Statement


Evofem Biosciences Income Statement

Last quarter (Q ), Evofem Biosciences's total revenue was $181.00K, a decrease of -94.93% from the same quarter last year. In Q, Evofem Biosciences's net income was $-11.48M. See Evofem Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 16.84M$ 16.84M$ 8.24M$ 446.00K$ 0.00$ 0.00
Cost of Revenue
$ 9.12M$ 4.42M$ -4.05M$ 468.00K$ 0.00-
Gross Profit
$ 12.42M$ 12.42M$ 4.19M$ -22.00K$ 0.00-
Operating Expense
$ 49.72M$ 96.55M$ -170.99M$ 103.60M$ 52.74M$ 77.64M
Operating Income
$ -84.12M$ -84.12M$ -166.80M$ -103.62M$ -52.74M$ -77.64M
Net Non Operating Interest Income Expense
$ -906.00K$ -72.91M$ 15.00K$ 169.00K$ 458.00K$ 127.00K
Other Income Expense
$ -994.00K$ -80.38M$ -38.39M$ -38.85M$ -27.75M$ -48.20M
Pretax Income
$ -76.65M$ -76.65M$ -205.18M$ -142.31M$ -80.03M$ -125.71M
Tax Provision
$ 18.00K$ 44.00K$ -17.00K$ 4.00K$ 4.00K$ 2.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -78.01M$ -78.01M$ -206.24M$ -142.31M$ -80.03M$ -125.78M
Basic EPS
$ -1.34$ -1.34$ -1.58$ -31.80$ -1.99$ -5.74
Diluted EPS
$ -1.34$ -1.34$ -1.58$ -31.80$ -1.99$ -5.74
Basic Average Shares
$ 178.90M$ 58.25M$ 130.91M$ 4.48M$ 40.23M$ 21.90M
Diluted Average Shares
$ 651.72M$ 58.25M$ 130.91M$ 4.48M$ 40.23M$ 21.90M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 58.83M$ 100.96M$ -175.04M$ 104.07M$ 52.74M$ 77.64M
Net Income From Continuing And Discontinued Operation
$ -76.70M$ -76.70M$ -205.19M$ -142.31M$ -80.03M$ -125.71M
Normalized Income
$ -95.70M--$ -115.47M$ -59.56M$ -90.64M
Interest Expense
$ 28.75M$ -3.75M$ -205.19M$ -103.62M$ -52.74M$ -77.64M
$ -59.95M$ -2.73M-$ -103.32M$ -52.48M$ -77.38M
Currency in USD

Evofem Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis